Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery.
Trial ID or NCT#
NCT00767832
Status
NOT RECRUITING
Purpose
The purpose of the study is to assess the coagulation changes that occur in patients undergoing elective Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.
Official Title
Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery.
Eligibility Criteria
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - All obstetric patients with singleton pregnancies admitted to the labor and delivery unit at Lucile Packard Hospital who undergo elective Cesarean delivery. - We will select 100 healthy ASA 1 patients with singleton pregnancies who are scheduled for uncomplicated elective Cesarean delivery, with no anticipated risk of obstetric hemorrhage.
Exclusion Criteria:
- - Patients with underlying coagulation disorders. - Patients with thrombocytopenia. - Patients with pregnancy-induced hypertension, pre-eclampsia. - Patients requiring the following medications prior to surgery: NSAIDS, aspirin, anticoagulants. - Patients requiring non-elective Cesarean delivery. - Patients with significant obstetric or medical disease. - No patients <18 years of age will be recruited.
Investigator(s)
Lindsey Ralls
Anesthesiologist
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Contact us to find out if this trial is right for you.
Contact
Alexander Butwick
View on ClinicalTrials.gov
